[
  {
    "ts": null,
    "headline": "UBS Maintains Buy Rating on Cigna (CI) Stock",
    "summary": "On Friday, May 23, UBS analyst AJ Rice reaffirmed a “Buy” rating on The Cigna Group (NYSE:CI) with a price target of $390. Rice shared his views after a recent investor event at the Evernorth Innovation Lab, which was held together with the company’s management team. The Cigna Group’s (NYSE:CI) strategic departure from the Medicare […]",
    "url": "https://finnhub.io/api/news?id=255973f0f33bbcf79a4ee077ff35142e57ea80212d9a3012b7c7d5a74173088a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748270968,
      "headline": "UBS Maintains Buy Rating on Cigna (CI) Stock",
      "id": 134716505,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CI",
      "source": "Yahoo",
      "summary": "On Friday, May 23, UBS analyst AJ Rice reaffirmed a “Buy” rating on The Cigna Group (NYSE:CI) with a price target of $390. Rice shared his views after a recent investor event at the Evernorth Innovation Lab, which was held together with the company’s management team. The Cigna Group’s (NYSE:CI) strategic departure from the Medicare […]",
      "url": "https://finnhub.io/api/news?id=255973f0f33bbcf79a4ee077ff35142e57ea80212d9a3012b7c7d5a74173088a"
    }
  }
]